How to be optimistic, responsible, and open in the face of new technology.
Alexis G. Malkin, OD, FAAO, and Anita Gulmiri, OD, FAAO, share highlights from their presentation, "Intersection of low vision and contact lens: unique examples of co-management," which they presented during AAOpt 2022.
Jack Phu, OD, MPH, PhD, with UNSW Sydney, discusses key takeaways from his AAOpt 2022 presentation that looked at visual fields in 2022.
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Mandy Sallach, OD, overviews initiatives being taken on by the company to combat pediatric myopia.
ODs who utilize technology will advance modern optometric care.
Effective management of turnover can have a big impact on revenue.
Consider 4 conditions when treating this patient population.
Anthony Wallace, Vice President and General Manager of the US Surgical Business at Bausch + Lomb, discussed the introduction of SeeLuma, a fully digital surgical visualization platform, and more at the 2023 ASCRS annual meeting in San Diego.
An overview of a case of SLK treated with complete ocular lavage facilitated by an irrigating eyelid retractor.
Tackle one of the biggest challenges in managing patients with glaucoma
Mike Brown, OD, MHS-CL, FAAO, shares how the significance of a pocket watch and Helen Keller serve as important lessons in patient care for ODs.
The prevailing message is that physicians have “a long way to go” in the optimization of management and prevention of myopic vitreoretinal disease.
Christi Closson, OD, FAAO, provides insight on what other ODs learned about Johnson & Johnson's contact lens technology.
An inside look into a retrospective study conducted from 2019 to 2023 that aimed to assess the effectiveness of treatment and prevention of the progression of uncomplicated acquired myopia through physiotherapeutic methods.
ODs have the rare opportunity to engage as well as educate patients on hypertension.
By taking a proactive approach to treatment, identify the “silent sufferers.”
Drs Erin Draper and Christopher Kuc reiterate the important role optometrists play in identifying biomarkers for neurodegenerative diseases in patients.
In a study, a xenon slide illuminator was employed to mimic natural outdoor colors, allowing researchers to test brightness perception using a brightness-matching method, explains Billy R. Hammond.
Jason Duncan, OD, FAAO, shares highlights from his AOA 2022 presentation, "Injection Basics," presented at this year's Optometry's Meeting in Chicago.
Michael Wolber, CEO of OCULUS USA, sits down with host Mile Brujic, OD, FAAO, to wander through Wolber's engineering background, his accidental passion for eye care, and how he envisions OCULUS paving the way for improved patient care.
Hear about the new innovations on the market—and coming soon—from Alcon.
What the data shows on myopia management
Alissa M. Coyne, OD, FAAO, FASOS, gives her number 1 tip for managing dry eye.
A pivotal phase 3 clinical trial found that SYD-101 met its 3-year primary end point for slowing pediatric myopia progression.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Technologies that improve treatment of ONHD and similar pathologies.